Tatsufumi Nakamura

发表

Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Direct Infection of Primary Salivary Gland Epithelial Cells by Human T Lymphotropic Virus Type I in Patients With Sjögren's Syndrome

T. Koji, K. Arima, Hideki Nakamura, 2015, Arthritis & rheumatology.

Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis

M. Motomura, M. Takamori, Tatsufumi Nakamura, 2013, Journal of Neuroimmunology.

Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals

J. Berzofsky, S. Nagataki, K. Migita, 1991, Journal of Clinical Immunology.

The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis

Yuetsu Tanaka, H. Ushirogawa, E. Matsuura, 2017, Virology Journal.

Novel Complications with HTLV‐1‐associated Myelopathy/Tropical Spastic Paraparesis: Interstitial Cystitis and Persistent Prostatitis

S. Nagataki, H. Kanetake, S. Hino, 1992, Japanese journal of cancer research : Gann.

Involvement of p38 MAPK signaling pathway in IFN-γ and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis

K. Eguchi, Yasuaki Yamada, S. Kohno, 2005, Journal of Neuroimmunology.

Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjögren's syndrome patients.

D. Sasaki, H. Hasegawa, J. Fukuoka, 2018, Clinical and experimental rheumatology.

Discordant Gerstmann-Sträussler-Scheinker disease in monozygotic twins

K. Eguchi, T. Yoshimura, R. Tsuda, 1998, The Lancet.

Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis

K. Eguchi, T. Fujimoto, S. Shirabe, 2002, Journal of the Neurological Sciences.

Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

K. Eguchi, R. Moriuchi, S. Katamine, 2004, The Tohoku journal of experimental medicine.

Human T‐cell leukemia virus type I–associated myelopathy following living‐donor liver transplantation

Y. Tajima, T. Kanematsu, S. Eguchi, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy

K. Eguchi, M. Motomura, S. Nakane, 1999, Journal of Neuroimmunology.

Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy

S. Nagataki, A. Tsujino, T. Yoshimura, 1997, Journal of the Neurological Sciences.

Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-I-associated myelopathy

K. Migita, K. Eguchi, A. Kawakami, 1999, Journal of Neuroimmunology.

Interferon-alpha treatment in HTLV-I-associated myelopathy Studies of clinical and immunological aspects

S. Nagataki, M. Tsujihata, S. Shirabe, 1991, Journal of the Neurological Sciences.

Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis

Tatsufumi Nakamura, 2000, Annals of medicine.

Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.

Yuetsu Tanaka, N. Araya, Yasuaki Yamada, 2011, Cellular immunology.

Antiproliferative factor against the human glioblastoma cell line T98G identified in culture supernatants of CD4+ cells from patients with HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, S. Shirabe, 1994, Journal of the Neurological Sciences.

Increased Fas-mediated cytotoxicity of CD4-positive T cells in patients with human T-lymphotropic virus type I-associated myelopathy

T. Nakashima, K. Eguchi, A. Kawakami, 1998, Journal of Neuroimmunology.

Live Cell Labeling with Terpyridine Derivative Proligands to Measure Cytotoxicity Mediated by Immune Cells

Yoshimasa Tanaka, S. Mizuta, C. Morita, 2017, ChemMedChem.

Title Intracellular cyclic adenosine monophosphate regulates the efficiency ofintercellular transmission of human T-lymphotropic virus type

K. Satoh, Hideki Nakamura, Tatsufumi Nakamura, 2018 .

Intracellular cyclic adenosine monophosphate regulates the efficiency of intercellular transmission of human T‐lymphotropic virus type I

K. Satoh, Hideki Nakamura, Tatsufumi Nakamura, 2014 .

Resistance of CD4-positive T lymphocytes to etoposide-induced apoptosis mediated by upregulation of Bcl-xL expression in patients with HTLV-I-associated myelopathy

T. Nakashima, K. Eguchi, A. Kawakami, 2001, Journal of Neuroimmunology.

Initial human T-cell leukemia virus type 1 infection of the salivary gland epithelial cells requires a biofilm-like structure.

Toshimasa Shimizu, Hideki Nakamura, A. Kawakami, 2019, Virus research.

Macrophage-dominant sialadenitis in HTLV-I-associated myelopathy post living-donor liver transplantation

Kawakami, S. Yamasaki, K. Eguchi, 2018 .

Title Reevaluation for clinical manifestations of HTLV-I-seropositive patientswith Sjögren ’ s syndrome

Shuntaro Sato, J. Fukuoka, Y. Takagi, 2018 .

Direct infection of primary salivary gland epithelial cells by HTLV-I that induces the niche of the salivary glands of Sjögren ’ s syndrome patients

T. Koji, K. Arima, Hideki Nakamura, 2017 .

Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren’s syndrome

Shuntaro Sato, J. Fukuoka, Y. Takagi, 2015, BMC Musculoskeletal Disorders.

HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjögren’s syndrome

S. Yamasaki, K. Ichinose, Hideki Nakamura, 2013, Modern rheumatology.

Low prevalence of ectopic germinal centre formation in patients with HTLV-I-associated Sjogren's syndrome.

S. Yamasaki, K. Eguchi, N. Iwamoto, 2009, Rheumatology.

Efficacy of tacrolimus in Sjögren’s syndrome-associated CNS disease with aquaporin-4 autoantibodies

K. Eguchi, M. Motomura, Hideki Nakamura, 2009, Journal of Neurology.

Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression.

A. Hida, S. Yamasaki, K. Migita, 2003, The Journal of laboratory and clinical medicine.

Expression and Function of X Chromosome-Linked Inhibitor of Apoptosis Protein in Sjögren's Syndrome

S. Yamasaki, T. Nakashima, Y. Hayashi, 2000, Laboratory Investigation.

Sequence heterogeneity of HTLV‐I proviral DNA in the central nervous system of patients with HTLV‐I–associated myelopathy

Y. Itoyama, E. Baba, J. Kira, 1994, Annals of neurology.

Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, M. Motomura, 1991, Journal of Neuroimmunology.

Further studies on bacterial lipopolysaccharide-induced protection against experimental allergic encephalomyelitis in guinea pigs Effects of chemical modifications

H. Shibasaki, K. Hisatsune, S. Kondo, 1982, Journal of the Neurological Sciences.

Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy

S. Nagataki, M. Tsujihata, K. Nagasato, 1994, Journal of the Neurological Sciences.

High prevalence of Sjögren’s syndrome in patients with HTLV-I associated myelopathy

S. Nagataki, K. Migita, K. Eguchi, 1997, Annals of the rheumatic diseases.

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients

S. Nagataki, K. Miyamoto, Tatsufumi Nakamura, 1992, Japanese journal of cancer research : Gann.

Intravesical injection of onabotulinumtoxinA in neurogenic overactive bladder patients with human T‐cell leukemia virus type 1‐associated myelopathy: A single‐institution case series

Y. Miyata, T. Matsuo, H. Sakai, 2021, IJU case reports.

Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy

K. Satoh, Y. Miyata, T. Matsuo, 2018, Lower urinary tract symptoms.

Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T‐lymphotropic virus type 1‐associated myelopathy/tropical spastic paraparesis

K. Satoh, Y. Miyata, T. Matsuo, 2018, International journal of urology : official journal of the Japanese Urological Association.

Fucoidan Therapy Decreases the Proviral Load in Patients with Human T-Lymphotropic Virus Type-1-Associated Neurological Disease

N. Mori, S. Aratani, T. Nakajima, 2011, Antiviral therapy.

HTLV-I Production Based on Activation of Integrin/Ligand Signaling in HTLV-I-Infected T Cell Lines Derived from HAM/TSP Patients

K. Eguchi, H. Ida, T. Aramaki, 2008, Intervirology.

Natural course of voiding function in patients with human T-cell lymphotrophic virus type 1-associated myelopathy

M. Matsuo, M. Noguchi, H. Kanetake, 2004, Journal of the Neurological Sciences.

HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: a case report

K. Eguchi, H. Goto, S. Kohno, 1998, Journal of the Neurological Sciences.

Production of granulocyte-macrophage colony stimulating factor by human T-lymphotropic virus type I-infected human glioma cells

S. Nagataki, M. Tsujihata, K. Nagasato, 1994, Journal of the Neurological Sciences.

HTLV-I associated myelopathy in an identical twin

S. Nagataki, M. Tsujihata, M. Motomura, 1990, The Lancet.

PLASMAPHERESIS IN TREATMENT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED MYELOPATHY

S. Nagataki, I. Tomita, A. Satoh, 1988, The Lancet.

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

S. Nagataki, A. Satoh, M. Tsujihata, 1994 .

Role of the macrophage in the pathogenesis of experimental autoimmune myasthenia gravis

S. Nagataki, I. Tomita, A. Satoh, 1988, Journal of the Neurological Sciences.

Experimental neonatal autoimmune myasthenia gravis: an immunohistochemical, ultrastructural and electrophysiological study of the motor end-plate

S. Nagataki, A. Satoh, M. Seto, 1995, Journal of the Neurological Sciences.

Antitumor effects of chloroquine/hydroxychloroquine mediated by inhibition of the NF-κB signaling pathway through abrogation of autophagic p47 degradation in adult T-cell leukemia/lymphoma cells

S. Nakahata, K. Morishita, K. Shimoda, 2021, PloS one.

Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome

S. Nagataki, K. Iwasa, Y. Nemoto, 1995, Journal of the Neurological Sciences.

Effect of myasthenic immunoglobulin G on motor end-plate morphology

A. Satoh, M. Tsujihata, M. Motomura, 2003, Journal of Neurology.

Reinduction of experimental allergic encephalomyelitis in convalescent Lewis rats with cyclophosphamide

H. Shibasaki, Tatsufumi Nakamura, R. Mori, 1985, Journal of the Neurological Sciences.

Resistance to ischemic conduction block of the peripheral nerve in hyperglycemic rats: An electrophysiological study

S. Nagataki, H. Takashima, M. Tsujihata, 1988, Muscle & nerve.

Human prion disease

K. Satoh, Tatsufumi Nakamura, 2021, Clinical and Experimental Neuroimmunology.

Neurogenic bladder in Lambert–Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

K. Eguchi, M. Motomura, K. Satoh, 2001, Journal of the Neurological Sciences.

Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease

H. Sasaki, Tadahiro Nakamura, K. Satoh, 2014, Journal of NeuroVirology.

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

H. Sasaki, K. Satoh, Hideki Nakamura, 2013, BMC Medicine.

Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP

M. Matsuoka, Kousuke Hanada, Yuetsu Tanaka, 2018, Retrovirology.

Increased sialyl Lewisx antigen-positive cells mediated by HTLV-1 infection in peripheral blood CD4+ T lymphocytes in patients with HTLV-1-associated myelopathy

K. Eguchi, A. Kawakami, S. Shirabe, 2002, Journal of Neuroimmunology.

HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.

Tatsufumi Nakamura, 2009, Folia neuropathologica.

Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

K. Eguchi, Tatsufumi Nakamura, Y. Nishiura, 2009, Central Nervous System Agents in Medicinal Chemistry.

Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis

K. Eguchi, Hideki Nakamura, H. Ida, 2008, Antiviral therapy.

Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: A preliminary study

S. Nagataki, K. Nagasato, Tatsufumi Nakamura, 1993, Journal of the Neurological Sciences.

Disulfide-Mediated Apoptosis of HTLV-I-Infected Cells in Patients with HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis

K. Eguchi, Hideki Nakamura, H. Ida, 2017 .

Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4+ T Cell Transmigrating Activity into the Tissues.

K. Satoh, Hideki Nakamura, Tatsufumi Nakamura, 2018, AIDS research and human retroviruses.

Involvement of C‐X‐C chemokine receptor type 4 signaling in the efficiency of intercellular transmission of human T‐lymphotropic virus type I

K. Satoh, Tatsufumi Nakamura, Naomi Fukushima, 2016 .

Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy

S. Nagataki, H. Goto, M. Motomura, 1998, Journal of the Neurological Sciences.

Prosultiamine treatment as a new therapeutic strategy in human T lymphotropic virus type I‐associated myelopathy/tropical spastic paraparesis

Tatsufumi Nakamura, 2013 .

Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjögren’s syndrome

S. Yamasaki, K. Eguchi, Y. Kawabe, 1999, Annals of the rheumatic diseases.

Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1

K. Yanagihara, D. Sasaki, H. Hasegawa, 2021, The Journal of international medical research.

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy

K. Yanagihara, H. Hasegawa, A. Okayama, 2017, BMC Immunology.

LONG-TERM FOLLOW-UP OF IMMUNOMODULATION IN TREATMENT OF HTLV-I-ASSOCIATED MYELOPATHY

S. Nagataki, M. Tsujihata, H. Matsuo, 1989, The Lancet.

Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study

E. Inoue, N. Araya, M. Nakagawa, 2017, Neurotherapeutics.

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues

Tatsufumi Nakamura, Tatsufumi Nakamura, Tatsufumi Nakamura, 2023, Pathogens.

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis

J. Kira, H. Yonezawa, Takahiko Ueno, 2020, Orphanet Journal of Rare Diseases.

Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP

M. Matsuoka, Kousuke Hanada, Yuetsu Tanaka, 2018, Retrovirology.

Yuetsu Tanaka, H. Ushirogawa, E. Matsuura, 2017, Virology Journal.

Inhibitory effect of HTLV‐1 infection on the production of B‐cell activating factors in established follicular dendritic cell‐like cells

K. Furukawa, M. Umeda, Hideki Nakamura, 2021, Immunity, inflammation and disease.

Heightened IgE response to mite antigens in inflammatory neuropathies

J. Kira, Y. Ohyagi, H. Matsuo, 1999, Journal of the Neurological Sciences.

Specificity of autoantibodies react with ω‐conotoxin MVIIC‐sensitive calcium channel in Lambert‐Eaton myasthenic syndrome

S. Nagataki, M. Tsujihata, M. Motomura, 1996, Muscle and Nerve.

Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact.

S. Nagataki, K. Eguchi, I. Yamashita, 1994, Antiviral research.

Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy.

S. Nagataki, K. Migita, K. Eguchi, 1997, Transplantation.

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

K. Omagari, S. Kohno, H. Kinoshita, 1998, Gut.

Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.

A. Hida, S. Yamasaki, T. Nakashima, 2000, The Journal of laboratory and clinical medicine.

Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

K. Eguchi, S. Kohno, Tatsufumi Nakamura, 2007, Internal medicine.

Clinical outcome and survival of secondary (AA) amyloidosis.

S. Yamasaki, K. Migita, K. Eguchi, 2003, Clinical and experimental rheumatology.

vaccine for immunotherapy of metastatic renal-cell cancer

G. Bartsch, K. Eguchi, T. Yoshimura, 1998 .

Increased production of inflammatory cytokines in cultured CD4+ cells from patients with HTLV-I-associated myelopathy.

S. Nagataki, H. Goto, T. Nakamura, 1996, The Tohoku journal of experimental medicine.

Functional evaluation of inhibition of autonomic transmitter release by autoantibody from lambert eaton myasthenic syndrome

Y. Hattori, M. Motomura, S. Kikuchi, 1998, Annals of neurology.

Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.

M. Tomonaga, S. Kamihira, K. Tsukasaki, 1993, Blood.

Antiphospholipid Antibodies in Patients with Myasthenia Gravis

S. Nagataki, A. Satoh, M. Tsujihata, 1994 .

Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.

K. Eguchi, T. Yoshimura, S. Nakane, 1999, Internal medicine.

Live Cell Labeling with Terpyridine Derivative Proligands to Measure Cytotoxicity Mediated by Immune Cells

Yoshimasa Tanaka, S. Mizuta, C. Morita, 2017, ChemMedChem.